Dendrimer applications - A review

International Journal of Pharma and Bio Sciences

Volumn 4, Issue 2, 2013, Pages

  Patel, H N ^a   Patel, P M ^a  

^a V P AND R P T P SCIENCE COLLEGE   (India)

Author keywords

Dendrimer; Dendritic polymers; Drug carriers; PAMAM

Indexed keywords

AMINOLEVULINIC ACID; CHITOSAN; CISPLATIN; CONTRAST MEDIUM; DENDRIMER; DIFLUNISAL; DNA; ENOXAPARIN; INK; KETOPROFEN; NUCLEIC ACID; PAINT; PILOCARPINE; POLYAMIDOAMINE; POLYURETHAN;

BIOMIMETICS; CANCER CHEMOTHERAPY; CATALYST; CHEMICAL REACTION; CHEMICAL STRUCTURE; DEEP VEIN THROMBOSIS; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG HALF LIFE; DRUG RELEASE; ENCAPSULATION; GENETIC TRANSFECTION; HYDROPHILICITY; INTRAOCULAR DRUG ADMINISTRATION; INTRAPULMONARY DRUG ADMINISTRATION; LIGHT HARVESTING SYSTEM; MAGNETIC RESONANCE ANGIOGRAPHY; METAL RECOVERY; MICELLE; MOLECULAR WEIGHT; MOLECULARLY TARGETED THERAPY; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; REVIEW; SEPARATION TECHNIQUE; SOLUBILITY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 84876988488     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Tomalia D.A, Baker.H, Dewald J.R, Hall M, Kallos G, Martin S, Roeck J, Ryder J and Smith P., Dendrimers II: Architecture, nanostructure and supramolecular chemistry, Macromolecules, 19: 2466 (1986).
2. Froehling P.E., Dendrimers and dyes - a review, Dyes and pigments, 48:187-195 (2001).
3. Hawker C.J. and Frechet J.M.J., 'Three-Dimensional Dendritic Macromolecules: Design, Synthesis and Properties' in new methods of polymer synthesis, edited by J.R.Ebdon and G.C.Eastmond, Chapman and Hall, New York, 290-330 (1995).
4. Karak N, Maiti S., 'Dendrimers and hyperbranched polymers-synthesis to applications' MD Publications Pvt Ltd, New Delhi: 1-47 (2008).
5. Service R.F., Dendrimer: dream molecules approach real applications, Science: 267,458-9 (1995).
6. Twyman L.J, Beezer A.E, .Esfand R, Hardy M.J and Mitchell J.C, The Synthesis of Water Soluble Dendrimers, and their application as possible drug delivery systems, Tetrahedron Lett,40:1743-1746 (1999).
7. Wells M and Crooks R.M., Surface and colloid science, J.Am.Chem.Soc, 16: 3988-3989 (1996).
8. Miller L.L, Kunugi Y, Canavesi A, Rigaunt S, .Moorefield C.N and Newkome G.R, Supramolecular photosensitive and electroactive materials, Chem.Mater.,10,1751 (1998).
9. Langer R, Dendrimers II: Architecture, nanostructure and supramolecular chemistry, Chem.Eng.Sci, 50:4109 (1995).
10. Duncan R. and Kopecek J, Soluble synthetic polymers as potential drug carrier and Dendrimers in medicine and biotechnology, Adv. Polym. Sci., 57, 51 (1984).
11. Brady P.A. and Levy E.G, Inorganic and organometallic macromolecules: design and applications, Chem. Ind, (London), 18:21(1995).
12. Tully D.C and Frechet J.M.J, Dendrimers at surfaces and interfaces: chemistry and applications, Chem. Commun, 1229, (2001).
13. Adronov A and Frechet J.M.J, Light Harvesting Dendrimers, Chem. Commun, 1701-1710 (2000).
14. Bolm C, Derrien N and Seger A, Internal/External use of Dendrimeric Catalyst, Syn.Lett, 387(1996).
15. Bhyrappa P, Young J.K, Moore J.S and Suslick K.S., shape selective discrimination of small Organic molecules, J.Am.Chem.Soc, 118, 5 (1996).
16. Hecht S and Frechet J.M.J, Dendritic encapsulation of function: applying Nature's site isolation principle from biomimetics to material science, Angew. Chem. Int.Ed, 40, 74 (2001).
17. Frechet J.M.J, Branched polymer-II, Science, 263: 1710 (1994).
18. Kim Y.H and Webster O.W, Hyper branched Polymers: Synthesis, Properties and Applications, Macromolecules, 25, 5561 (1992).
19. Kim Y.H and Becherbauer.R, Advanced Polymeric Materials: Structure Property Relationship, Macromolecules, 27, 1968 (1994).
20. Duncan R, Malik N, Richardon S. and Ferruti P, Dendrimer nanocomposites in medicine, Polym.Prep, 39, 180 (1998).
21. Jain N.K Advances in Controlled and Novel Drug Delivery 'CBS Publishers & Distributors Pvt.Ltd.Reprint, 361-380. (2010).
22. Kobayashi H and Brechbiel N.W, Dendrimer- based macromolecular MRI contrast agents, Mol. Imaging, 2(1):1-10 (2003).
23. Sonke S and Tomalia D.A, Dendrimers in biomedical applications reflections on the Field, Advanced Drug Delivery Reviews, 57, 2106-2129, (2005).
24. Boas U, Christensen J.B and Heegaard P.M.H Dendrimers in Medicine and Biotechnology' RSC Publishing, The Royal Society of Chemistry, 81,103,152-154, (2006).
25. Haesnler J and Szoka F.C, Polymeric gene delivery: Principles and applications, Bioconj .Chem, 4, 372. (1993).
26. KukowskaLatallo J.F, Bielinska A.U, Johnson J, Spindler R, Tomalia D.A and Baker J.R., Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers, Proc.Nat Acad.Sci, USA, 93(10): 4897-4902(1996).
27. Denning J, Dendrimers in medicine and biotechnology, Top.Curr.Chem, 228, 227, (2003).
28. Eichman J.D, Bielinska A.U, Kukowska- Latallo J.F, Baker J.R, Jr, The use of PAMAM dendrimers in the efficient transfer of genetic material into cells, Pharm. Sci. Technol. Today, 3: 232-245. (2000).
29. Bielinska A.U, Chen C, Johnson J, Baker J.R. Jr, DNA complexing with polyamidoamine dendrimers: implications for transfection, Bioconjug. Chem, 10:843-850, (1999).
30. Shah D.S, Sakthivel T, Toth I, Florence A.T, Wilderspin A.F, DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers, Int. J. Pharm, 208: 41-48. (2000).
31. Hughes J.A, Aronsohn A.I, Avrutskaya A.V, Juliano R.L, Evaluation of adjuvant that enhance the effectiveness of antisense oligodeoxynucleotides, Pharm. Res, 13:404-410, (1996)
32. Juliano R.L, Alahari S, Yoo H, Kole R, Cho M., Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides, Pharm. Res, 16:494-502, (1999).
33. I. Lebedeva, L. Benimetskaya, C.A. Stein, M. Vilenchik, Cellular delivery of antisense oligonucleotides, Eur. J. Pharm. Biopharm, 50: 101-119, (2000).
34. Jaaskelainen I, Peltola S, Honkakoski P, Monkkonen J, Urtti A, A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides, Eur. J. Pharm. Sci, 10: 187-193, (2000).
35. Dass C.R, Vehicles for oligonucleotide delivery to tumors, J. Pharm. Pharmacol., 54: 3-27, (2002).
36. Jaffrès P.A, Morris R.E, Synthesis of highly functionalized dendrimers based on polyhedral silsesquioxane cores, J. Chem. Soc, Dalton Trans. 2767-2770. (1998).
37. Richardson S.C.W, Pattrick N.G, Man Y.K.S, Ferruti P, Duncan R, Poly(amidoamine)s as potential nonviral vectors: ability to form interpolyelectrolyte complexes and to mediate transfection in vitro, Biomacromolecules, 2:1023-1028, (2001).
38. Ferruti P, Marchisio M.A, Duncan R, Poly (amido-amine) s: biomedical applications, Macromol. Rapid Commun, 23:332-355, (2002).
39. Joester D, Losson M, Pugin R, Heinzelmann H, Walter E, Merkle H.P, Diederich F, Amphiphilic dendrimers: novel self-assembling vectors for efficient gene delivery, Angew. Chem, Int. Ed. Engl, 42:1486-1490, (2003).
40. Malik N, Evagorou E.G, Duncan R, Dendrimer-platinate: a novel approach to cancer chemotherapy, Anticancer Drugs, 10:767-776, (1999).
41. Balogh, L, Swanson D.R, Tomalia D.A, Hagnauer G.L, McManus A.T, Dendrimer-silver complexes and nanocomposites as antimicrobial agents, Nano Lett, 1:18-21, (2001).
42. (a) Malik N, Duncan R, Dendritic-platinate drug delivery system, US 6:585,956, (2003).
43. (b) Malik N, Duncan R, Method of treating cancerous tumors with a dendriticplatinate drug delivery system, US 6:790, 437, (2004).
44. Abhilash M., Potential applications of Nanoparticles, International Journal of Pharma and Bio Sciences, V1:1 (2010).
45. Nanjwade B.K., Kishore V.S., Thakare S. A., Novel Drug Delivery Systems and Regulatory Affairs. IKON BOOKS, Publishers and Distributors, New Delhi, 1-4, 29-33, (2011).
46. Cheng Y, Man N, Xu T, Fu R, Wang X, Wang X, Wen L, Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers, J. Pharm. Sci., 96: 595-602, (2007).
47. Csaba N, Garcia-Fuentes M, Alonso M.J, The performance of nanocarriers for transmucosal drug delivery, Expert. Opin. Drug Deliv, 3:463-478, (2006).
48. Jevprasesphant R, Penny J, Attwood D, McKeown N.B, D'Emanuele A, Engineering of dendrimer surface to enhance transepithelial transport and reduce cytotoxicity, Pharm. Res., 20 b 1543-1550, (2003).
49. Tolia G.T, Choi H.H and Ahsan F, The role of dendrimers in drug delivery, Pharmaceut. Tech., 32, 88-98, (2008).
50. Vandamme T.F, Brobeck L, Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide, J. Control. Release, 102(1): 23-38, (2005).
51. Bai S, Thomas C, Ahsan F, Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low molecular weight heparin, J. Pharm. Sci, 96, 2090-2106, (2007).
52. Jain N.K and Gupta U, Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability, Expert Opin Drug Metab Toxicol, 8, 1035-1045,(2008).
53. Winnick F.M, Duff J.M, Sacripante G. G, Davidson A. R. (Xerox Corp.), USA 5256516 A 931026, (1993); Chem. Abstr, 120, 90707i,(1994).
54. Nantalaksakul A, Reddy D. R, Ahn T.-S., Kaysi R.-A, Bardeen C. J, Thayumanavan, S, "Dendrimer Analogues of Linear Molecules to Evaluate Energy and Charge-Transfer Properties", Org. Lett., 8, 2981-2984, (2006).
55. Knapen J.W.J, vander Made A.W, de Wilde J.C, van Leeuwen P.W.N.M, Wijkens P, Grove D.M. and van Koten G, Dendrimer-Stabilized Palladium Nanoparticles, Nature,372, 659-663,(1994).
56. Brunner H, Dendrimer IV: Metal Coordination, Self Assembly, Catalysis, J.Organomet.Chem, 500, 39, (1995).
57. Cooper A.I, Londono J.D, Wignall G, McClain J.B, Samulski E.T, Lin J.S, Dobrynin A., Rubinstein M, Burke A.L.C, Fréchet J.M.J, & DeSimone, J.M. Extraction of a hydrophilic compound from water into liquid CO2 using dendritic surfactants, Nature,389, 368-371, (1997).
58. Sashiwa H, Yajima H, S. Aiba, Synthesis of a chitosan- dendrimer hybrid and its biodegradation, Biomacromolecules, 4, 1244-1249,(2003).
59. Bracci L, Falciani C, Lelli B, Lozzi L, Runci Y, Pini A, De Montis M.G, Tagliamonte A. and Neri P, Dendrimer in medicine and biotechnology, J.Biol.Chem, 278, 46590, (2003).
60. Diallo M, Christie S, Swaminathan P, Johnson J. and Goddard W, "Dendrimer enhanced ultrafiltration. Recovery of Cu (II) from aqueous solution using PAMAM dendrimers with ethylene diamine core and terminal NH2 groups," Environmental Science and Technology, Vol. 39, No. 5:1366-1377, (2005).
61. Xu Y-H. And D-Y. Zhao, Removal of copper from contaminated soil by use of poly (amidoamine) dendrimers, Environ. Sci. Technol, 39, 2369-2375, (2005).
62. Cohen, S. M, Petoud S, and Raymond K. N, Use of Dendrimers to Enhance Selective Separation of Nanofiltration and Reverse Osmosis Membranes, Chem. Eur. J, 7(1) 272-279, (2001).
63. Rether A. and Schuster M, Selective separation and recovery of heavy metal ions using water soluble Nbenzoylthiourea modified PAMAM polymer, Reactive and Functional Polymers, 57, 13-21,(2003).
64. Arkas M, Tsiourvas D. and Paleos C.M, Functional Dendrimeric "Nanosponges" for the Removal of Polycyclic Aromatic Hydrocarbons from water, Chem. Mater, 15, 2844-2847, (2003).
65. Pistilis, G. and Malliaris A, Use of Dendrimer to Enhance Selective Separation of Nanofiltration and Reverse Osmosis Membranes, Langmuir, 18, 246-251, (2002).